601
Participants
Start Date
November 30, 2005
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Radiotherapy
"External Beam Radiation 46Gy in 23 daily fractions~High Dose Brachytherapy 2 fractions of 9Gy"
Radiotherapy
"External Beam Radiotherapy 46Gy in 23 daily fractions~High Dose Brachytherapy 4 fractions of 7Gy"
Radiotherapy/Cisplatin
"External Beam Radiation 46Gy in 23 daily fractions~High Dose Brachytherapy 2 fractions of 9Gy~Cisplatin 40 mg/sqm weekly"
Radiotherapy/Cisplatin
"External Beam Radiotherapy 46Gy in 23 daily fractions~High Dose Brachytherapy 4 fractions of 7Gy~Cisplatin 40mg/sqm weekly"
University of Vienna; Department of Radiotherapy and Radiobiology, Vienna
rmandade de Santa Casa de Misericordia de Porto Alegre; Hospital Santa Rita, Porto Alegre
Peel Regional Cancer Centre, Mississauga
Department of Atomic Energy (DAE); Tata Memorial Centre (TMC); Tata, Mumbai
Institut National d'Oncologie, Rabat
Radiotherapy and Oncology University Clinic, Skopje
Bahawalpur Institute of Nuclear Medicine and Oncology (BINO), Bahawalpur
Instituto Nacional de Enfermedades Neoplásicas, Lima
Department of Radiation Oncology, Groote Schuur Hospital, Cape Town
National Cancer Center, Seoul
Christie Hospital; NHS Trust, Manchester
Lead Sponsor
International Atomic Energy Agency
OTHER_GOV